Empirical therapy for osteomyelitis in children

For empirical therapy for children younger than 4 years with long-bone or vertebral osteomyelitis who do not have sepsis or septic shock, use:

1cefazolin 50 mg/kg up to 2 g intravenously, 8-hourly. See advice on intravenous to oral switch and duration of therapy cefazolin

OR

2flucloxacillin 50 mg/kg up to 2 g intravenously, 6-hourly. See advice on intravenous to oral switch and duration of therapy. flucloxacillin

For empirical therapy for children 4 years or older with long-bone or vertebral osteomyelitis who do not have sepsis or septic shock, use:

1cefazolin 50 mg/kg up to 2 g intravenously, 8-hourly. See advice on intravenous to oral switch and duration of therapy cefazolin

OR

1flucloxacillin 50 mg/kg up to 2 g intravenously, 6-hourly. See advice on intravenous to oral switch and duration of therapy. flucloxacillin

For children at increased risk of methicillin-resistant Staphylococcus aureus (MRSA) infection, add vancomycin to either of the regimens above. Add:

In some regions, based on local susceptibility data, clindamycin is a suitable alternative to vancomycin. Consider:

clindamycin 15 mg/kg up to 600 mg intravenously, 8-hourly1. See advice on intravenous to oral switch and duration of therapy. clindamycin

For children who have had a nonsevere (immediate or delayed) hypersensitivity reaction to a penicillin, use cefazolin (see dosage above).

For children who have had a severe immediate2 hypersensitivity reaction to a penicillin, cefazolin (at the dosage above) can be considered if a beta-lactam antibiotic is strongly preferred (for considerations, see Severe immediate hypersensitivity: Implications of cross-reactivity between penicillins and cephalosporins).

For children who have had a severe immediate2 hypersensitivity reaction to a penicillin in whom cefazolin is not used, or for children who have had a severe delayed3 hypersensitivity reaction to a penicillin, use vancomycin (see dosage above) or seek expert advice if K. kingae infection is suspected.

1 There are more clinical and microbiological data to support the use of clindamycin than lincomycin. Intravenous lincomycin can be used at the same dosage if clindamycin is unavailable or if a local protocol recommends its use.Return
2 Severe immediate hypersensitivity reactions include anaphylaxis, compromised airway, airway angioedema, hypotension and collapse.Return
3 Severe delayed hypersensitivity reactions include cutaneous adverse drug reactions (eg drug rash with eosinophilia and systemic symptoms [DRESS], Stevens–Johnson syndrome/toxic epidermal necrolysis [SJS/TEN], severe blistering or desquamative rash), and significant internal organ involvement (eg acute interstitial nephritis).Return